From the point of view of efficacy in terms of recombinant antibody, does anyone have practical experience that it is more advantageous to produce the light and heavy chains together or separately?
While light chains can form light chain dimers and therefore form a properly folded, soluble species, the CH1 domain of normal antibodies is very unstable and aggregation prone in absence of a CL1 domain. Camelid heavy-chain only antibodies not only lack the light chain, but they also lack the CH1 domain, so they circumvent the problem of having an unpaired CH1 domain.